Scientists sound warning note over malaria drug resistance in Africa

Rwanda study raises fears erosion of efficacy may have begun, with children at greatest risk

Resistance to malaria drugs in Africa may be starting to take hold, according to a study that maps changes similar to those seen a decade ago when drug resistance spread in south-east Asia.

In Cambodia and neighbouring countries, the artemisinin drug compounds widely used against malaria are no longer always effective. The falciparum malaria parasites have developed genetic mutations that allow them to evade the drugs. There has been great concern that drug resistance could spread to Africa, which has the highest burden of cases of this type of malaria – and the highest toll of child deaths from it.

A study in Rwanda, published in the Lancet Infectious Diseases journal on Wednesday, shows that the feared erosion of efficacy of the malaria drugs may have begun. As happened in south-east Asia, researchers have found that giving a child a course of artemisinin compound drugs does not always clear the malaria parasites from their blood in three days, as it should.

Artemisinins, introduced in the early 2000s from China, are given in combination with a different type of malaria drug to ensure all parasites are cleared and the efficacy of the drugs is not compromised. The most common combination is artemether-lumefantrine, which Rwanda began to use in 2006.

If the artemisinin drug does not clear the parasites promptly within three days, the partner drug comes under pressure and resistance to it may develop in turn. At that point, the treatment may fail, as has happened in south-east Asia.

“Mutations can emerge spontaneously, and previous studies have pointed to isolated cases of resistance. However, our new study shows that resistant isolates are starting to become more common and most importantly, are associated with clinical implications [delayed parasite clearance],” said lead author Dr Aline Uwimana, from the Rwanda Biomedical Centre, in Kigali.

The experts called for more intensive surveillance of drug resistance in Rwanda and other African countries. “Our study showed that the treatment for malaria in Rwanda is still 94% effective, but new studies and ongoing monitoring are urgently needed,” said co-author Dr Naomi Lucchi, CDC resident adviser for the US President’s Malaria Initiative.

The researchers monitored the treatment of 224 children with malaria aged six months to five years in three areas of Rwanda – Masaka, Rukara and Bugarama. In two of the sites, about 15% of children still had detectable parasites after three days, fitting the World Health Organization (WHO) criteria for partial resistance.

The researchers also found certain mutations in the parasites, which are implicated by the WHO in delayed clearance.

Experts believe the warning signs are there. This study, and other data, suggest we are “on the verge of clinically meaningful artemisinin-resistance in Africa, as emerged in south-east Asia over a decade ago”, writes Prof Philip Rosenthal, of the University of California, San Francisco, in a commentary in the journal.

“Loss of efficacy of key ACTs [artemisinin-based combination therapies], particularly artemether-lumefantrine, the most widely used antimalarial, could have dire consequences, as occurred when chloroquine resistance led to enormous increases in malaria deaths in the late 20th century.”

It was impossible to predict the pace of progression in Africa, but close surveillance of the development of resistance in the parasite – with prompt replacement of failing regimens – “could save many lives”, he said.


Sarah Boseley, health correspondent

The GuardianTramp

Related Content

Article image
WHO endorses use of world’s first malaria vaccine in Africa
World Health Organization’s director general hails ‘historic day’ in fight against parasitic disease

Lizzy Davies

06, Oct, 2021 @5:17 PM

Article image
Malaria campaigns fight off Covid disruptions to deliver programmes
Almost all programmes against the disease have continued, delivering nets, drugs and the world’s first malaria vaccine

Samuel Okiror in Kampala

02, Oct, 2020 @12:26 PM

Article image
Invest in mosquito surveillance to combat malaria, says Bill Gates
Gates stresses need to track geographical spikes in disease as Commonwealth nations pledge £2.7bn to halt deadly resurgence

Hannah Summers

18, Apr, 2018 @8:00 AM

Article image
Malaria is back on the rise as lack of funds stalls push to wipe out disease
The WHO’s 2017 malaria reports says progress in fighting disease has slowed, and more money is needed to reach elimination target

Karen McVeigh

29, Nov, 2017 @5:00 AM

Article image
Child malaria deaths dramatically cut by suppository drug, shows Zambia study
Internally administered medicine allows crucial window of time for children in remote areas to reach healthcare facilities

Rebecca Ratcliffe

25, Oct, 2018 @6:00 AM

Article image
Scientists hail malaria breakthrough as bed nets prove deadly to mosquitoes
Clinical malaria cases in Burkina Faso drop by 12% after trial of nets treated with new chemical combination

Kate Hodal

11, Aug, 2018 @8:00 AM

Article image
Malaria breakthrough as scientists find ‘highly effective’ way to kill parasite
Drugs derived from Ivermectin, which makes human blood deadly to mosquitoes, could be available within two years

Gitonga Njeru in Nairobi

05, Sep, 2019 @6:00 AM

Article image
Climate crisis ‘may put 8bn at risk of malaria and dengue’
Reducing global heating could save millions of people from mosquito-borne diseases, study finds

Saeed Kamali Dehghan

08, Jul, 2021 @6:00 AM

Article image
Mosquito-killing spider juice offers malaria hope
Scientists have genetically modified a fungus to make it produce the same lethal toxin as is found in the funnel web spider

Rebecca Ratcliffe

31, May, 2019 @12:22 PM

Article image
Big pharma can only see the benefit of R&D for wealthy markets | Kenan Malik
There is too little incentive for pharmaceutical companies to work on treatments for diseases of low-income countries

Kenan Malik

05, May, 2019 @5:00 AM